[Adjuvant therapy (phenol, bone cement) in giant cell tumors].
69 patients were treated with giant-cell tumors in the Orthopaedic Department of the Semmelweis Medical School in Budapest between 1975-1989. The recurrence rate was 15 cases in 36 patients who were treated with curettage and spongiosa plasty only. In 11 cases the curettage was combined with adjuvants (phenol and/or filling with bone cement). This way the recurrence rate could be decreased to 1 case out of 11. The use of phenol and bone cement proved to be useful adjuvants to the surgical curettage at the giant-cell tumors and without complications.
Szendröi
M
M
Orthopädische Klinik Semmelweis Universität, Budapest, Ungarn.
D000328:Adult; D001843:Bone Cements; D001859:Bone Neoplasms / Q000000981:diagnostic imaging / Q000601:surgery*; D003131:Combined Modality Therapy; D005260:Female; D005269:Femur / Q000000981:diagnostic imaging / Q000601:surgery; D005500:Follow-Up Studies; D005870:Giant Cell Tumors / Q000000981:diagnostic imaging / Q000601:surgery*; D006801:Humans; D008297:Male; D019800:Phenol; D010636:Phenols / Q000008:administration & dosage*; D011183:Postoperative Complications / Q000000981:diagnostic imaging; D011859:Radiography; D013977:Tibia / Q000000981:diagnostic imaging / Q000601:surgery
D001843:Bone Cements; D010636:Phenols; D019800:Phenol
Adjuvante Therapie (Phenol, Knochenzement) bei den Riesenzelltumoren.